Percutane hartklep implantatie bij congenitale en ... - KCE

More documents

Recommendations

Info

viii Percutane hartklepimplantatie KCE reports 95A Bij deze conditionele terugbetaling moet elke behandelde patiënt uitvoerig geregistreerd en gedocumenteerd worden. Jaarlijks dient een evaluatie van de behandelde gevallen te gebeuren met bijzondere aandacht voor de peri-procedurale mortaliteit en de korte termijn doeltreffendheid van de prothese. Na verloop van tijd zal ook langere termijn informatie beschikbaar zijn van de patiëntenreeks van dr. Bonhoeffer en mogelijk ook van andere onderzoekers.
KCE Reports 95 Percutaneous Heart Valves 1 Scientific Summary Table of contents GLOSSARY ................................................................................................................................. 3 SCOPE ......................................................................................................................................... 5 1 CLINICAL BACKGROUND ........................................................................................... 6 1.1 AORTIC VALVE DISEASE .......................................................................................................................... 6 1.2 RIGHT VENTRICULAR OUTFLOW TRACT DISEASE...................................................................... 8 1.3 CARDIAC VALVE SURGERY IN BELGIUM.........................................................................................10 2 PERCUTANEOUS HEART VALVES .......................................................................... 12 2.1 PERCUTANEOUS AORTIC VALVE (PAV)..........................................................................................12 2.1.1 The Edwards PAV ..........................................................................................................................13 2.1.2 The CoreValve PAV ......................................................................................................................15 2.2 PERCUTANEOUS PULMONARY VALVE (PPV) ................................................................................16 2.3 REGULATORY STATUS...........................................................................................................................17 2.3.1 EU vs. US..........................................................................................................................................17 2.3.2 Ongoing studies..............................................................................................................................18 2.3.3 Conditional reimbursement of medical devices in Belgium ..................................................19 3 CLINICAL EFFECTIVENESS ....................................................................................... 22 3.1 LITERATURE SEARCH..............................................................................................................................22 3.1.1 Search strategy and eligibility.......................................................................................................22 3.1.2 Data extraction...............................................................................................................................23 3.2 LITERATURE REVIEW – PERCUTANEOUS AORTIC VALVE........................................................24 3.2.1 Health technology assessments...................................................................................................24 3.2.2 Case series of PAV insertion .......................................................................................................26 3.3 LITERATURE REVIEW – PERCUTANEOUS PULMONARY VALVE .............................................34 3.3.1 Health technology assessments...................................................................................................34 3.3.2 Case series.......................................................................................................................................35 4 PATIENT ISSUES.......................................................................................................... 38 4.1 PERCUTANEOUS AORTIC VALVE ......................................................................................................38 4.2 PERCUTANEOUS PULMONARY VALVE............................................................................................39 5 COST CONSIDERATIONS.......................................................................................... 40 5.1 COST INFORMATION.............................................................................................................................40 5.1.1 NIHDI...............................................................................................................................................40 5.1.2 TCT...................................................................................................................................................41 5.1.3 An early short-term cost analysis for PPV replacement........................................................42 5.2 COST EFFECTIVENESS OF PERCUTANEOUS HEART VALVES: A REVIEW OF THE LITERATURE ...............................................................................................................................................47 5.2.1 Methods............................................................................................................................................47 5.2.2 Results ..............................................................................................................................................47 5.3 GATHERING (COST) INFORMATION IN TIME ..............................................................................49 5.3.1 Gathering information to be able to perform a full economic evaluation .........................50 5.3.2 Gathering information to be able to estimate the budget impact .......................................51 6 ORGANISATIONAL ISSUES....................................................................................... 54 7 DISCUSSION ................................................................................................................. 55 7.1 PERCUTANEOUS AORTIC VALVE INSERTION ..............................................................................55 7.1.1 Appropriateness .............................................................................................................................55 7.1.2 Feasibility..........................................................................................................................................55 7.1.3 Safety.................................................................................................................................................56 7.1.4 Clinical effectiveness......................................................................................................................60 7.1.5 Cost effectiveness ..........................................................................................................................60 7.1.6 Scientific evaluation........................................................................................................................62 7.2 PERCUTANEOUS PULMONARY VALVE INSERTION....................................................................64 7.2.1 Appropriateness .............................................................................................................................64
Page 1 and 2: Percutane hartklepimplantatie bij c
Page 3 and 4: Percutane hartklepimplantatie bij c
Page 5 and 6: KCE reports 95A Percutane hartklepi
Page 11: KCE reports 95A Percutane hartklepi
Page 15 and 16: KCE Reports 95 Percutaneous Heart V
Page 63 and 64:
KCE Reports 95 Percutaneous Heart V
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
KCE Reports vol Percutaneous Heart
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91:
Page 94 and 95:
Wettelijk depot : D/2008/10.273/79
Page 96 and 97:
38. Baarmoederhalskankerscreening e
show all

Percutane hartklep implantatie bij congenitale en ... - KCE

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?